BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10208665)

  • 1. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer.
    Sanguineti G; Corvo R; Benasso M; Margarino G; Sormani M; Roncallo F; Mereu P; Bacigalupo A; Vitale V
    Head Neck; 1999 May; 21(3):223-8. PubMed ID: 10208665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.
    Lavertu P; Adelstein DJ; Saxton JP; Secic M; Wanamaker JR; Eliachar I; Wood BG; Strome M
    Head Neck; 1997 Oct; 19(7):559-66. PubMed ID: 9323143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy pf cervical lymph node metastases of unknown primary tumor].
    Kirschner MJ; Fietkau R; Waldfahrer F; Iro H; Sauer R
    Strahlenther Onkol; 1997 Jul; 173(7):362-8. PubMed ID: 9265258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer.
    Boyd TS; Harari PM; Tannehill SP; Voytovich MC; Hartig GK; Ford CN; Foote RL; Campbell BH; Schultz CJ
    Head Neck; 1998 Mar; 20(2):132-7. PubMed ID: 9484944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of chemotherapy and radiotherapy in sterilizing cervical nodal disease in squamous cell carcinoma of the head and neck.
    Moore MG; Bhattacharyya N
    Laryngoscope; 2005 Apr; 115(4):570-3. PubMed ID: 15805860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results.
    Adelstein DJ; Saxton JP; Lavertu P; Tuason L; Wood BG; Wanamaker JR; Eliachar I; Strome M; Van Kirk MA
    Head Neck; 1997 Oct; 19(7):567-75. PubMed ID: 9323144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.
    Porceddu SV; Campbell B; Rischin D; Corry J; Weih L; Guerrieri M; Grossi M; Peters LJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):365-73. PubMed ID: 15380568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Watch-and-see" policy for the clinically positive neck in head and neck cancer treated with chemoradiotherapy.
    Homma A; Furuta Y; Oridate N; Suzuki F; Higuchi E; Nishioka T; Shirato H; Nagahashi T; Yagi K; Fukuda S
    Int J Clin Oncol; 2006 Dec; 11(6):441-8. PubMed ID: 17180512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study.
    Abitbol AA; Schwade JG; Lewin AA; Sridhar K; Brandon AH; Markoe AM; Casiano RR; Houdek PV; Serago C; Miller DJ
    Am J Clin Oncol; 1992 Jun; 15(3):250-5. PubMed ID: 1590280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresectable primary tumor of head and neck: does neck dissection combined with chemoradiotherapy improve survival?
    Carinci F; Cassano L; Farina A; Pelucchi S; Calearo C; Modugno V; Nielsen I; Api P; Pastore A
    J Craniofac Surg; 2001 Sep; 12(5):438-43. PubMed ID: 11572248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
    Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
    J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
    Kohno N; Kitahara S; Tamura E; Tanabe T
    Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?
    Narayan K; Crane CH; Kleid S; Hughes PG; Peters LJ
    Head Neck; 1999 Oct; 21(7):606-13. PubMed ID: 10487947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.